InvestorsHub Logo
Followers 61
Posts 11577
Boards Moderated 0
Alias Born 07/16/2006

Re: None

Friday, 09/21/2018 2:55:28 PM

Friday, September 21, 2018 2:55:28 PM

Post# of 20689
Good News - Bad News


GOOD NEWS:

IT'S FRIDAY


BAD NEWS:

I misread the IMS report two weeks ago and it's not as bright as I reported. My Apologies. While the TRX numbers suck they should improve as the NRX numbers mature.


Current Report Of Copaxone TRX Sales:

Teva 40MG 66%
TEVA 20MG 11%

MYLAN 40MG 15% (1746)
MYLAN 20MG 1%

SANDOZ 40MG 2%
SANDOZ 20MG 4% (513)


CURRENT REPORT OF COPAXONE NRX SALES:

TEVA 40MG 38%
TEVA 20MG 8%

MYLAN 40MG 29%
MYLAN 20MG 6%

SANDOZ 40MG 12%
SANDOZ 20MG 7%